OBJECTIVE: To investigate the effect of HBP-A on meniscal injuries and the expressions of genes associated with pathological hypertrophy and calcification of the meniscusinduced by abnormal loading. METHODS: Bovine meniscus explants were subjected to 25% strain at 0.3 Hz for 3 h and treated with 0.6 mg/mL of HBP-A. The cell viability in the meniscus explants after 72 hin culture was determined using live/dead staining and the expression levels of genes associated with pathological hypertrophy and calcification of the meniscus (ANKH, ENPP1, ALP, MMP13, and IL-1) were measured using real-time PCR and Western blotting. The conditioned medium was collected for testing sulfated glycosaminoglycan (GAG) release. RESULTS: The number of dead cells, loss of proteoglycan content, and the expressions of ANKH, ENPP1, ALP and MMP13, and IL-1 at both the mRNA and protein levels were all significantly lower in the meniscus explants treated with 0.6 mg/mL HBP-A than in the explants with only 25% abnormal pressure stimulation (n=3, P<0.05). CONCLUSION: HBP-A can effectively alleviate meniscal injuries induced by abnormal loading and suppress the expressions of genes related with pathological hypertrophy and calcification of the meniscus, and can serve as a potential drug for treatment of knee osteoarthritis.
OBJECTIVE: To investigate the effect of HBP-A on meniscal injuries and the expressions of genes associated with pathological hypertrophy and calcification of the meniscusinduced by abnormal loading. METHODS:Bovine meniscus explants were subjected to 25% strain at 0.3 Hz for 3 h and treated with 0.6 mg/mL of HBP-A. The cell viability in the meniscus explants after 72 hin culture was determined using live/dead staining and the expression levels of genes associated with pathological hypertrophy and calcification of the meniscus (ANKH, ENPP1, ALP, MMP13, and IL-1) were measured using real-time PCR and Western blotting. The conditioned medium was collected for testing sulfated glycosaminoglycan (GAG) release. RESULTS: The number of dead cells, loss of proteoglycan content, and the expressions of ANKH, ENPP1, ALP and MMP13, and IL-1 at both the mRNA and protein levels were all significantly lower in the meniscus explants treated with 0.6 mg/mL HBP-A than in the explants with only 25% abnormal pressure stimulation (n=3, P<0.05). CONCLUSION: HBP-A can effectively alleviate meniscal injuries induced by abnormal loading and suppress the expressions of genes related with pathological hypertrophy and calcification of the meniscus, and can serve as a potential drug for treatment of knee osteoarthritis.
Authors: F Wei; J Zhou; X Wei; J Zhang; B C Fleming; R Terek; M Pei; Q Chen; T Liu; L Wei Journal: Osteoarthritis Cartilage Date: 2012-03-30 Impact factor: 6.576
Authors: Guoqing Du; Hongsheng Zhan; Daofang Ding; Shaowei Wang; Xiaochun Wei; Fangyuan Wei; Jianzhong Zhang; Bahar Bilgen; Anthony M Reginato; Braden C Fleming; Jin Deng; Lei Wei Journal: Am J Sports Med Date: 2016-01-20 Impact factor: 6.202
Authors: M Attur; A Statnikov; J Samuels; Z Li; A V Alekseyenko; J D Greenberg; S Krasnokutsky; L Rybak; Q A Lu; J Todd; H Zhou; J M Jordan; V B Kraus; C F Aliferis; S B Abramson Journal: Osteoarthritis Cartilage Date: 2015-11 Impact factor: 6.576
Authors: Yubo Sun; David R Mauerhan; Patrick R Honeycutt; Jeffrey S Kneisl; James H Norton; Edward N Hanley; Helen E Gruber Journal: BMC Musculoskelet Disord Date: 2010-01-28 Impact factor: 2.362
Authors: Hansjörg Rothe; Vincent Brandenburg; Margot Haun; Barbara Kollerits; Florian Kronenberg; Markus Ketteler; Christoph Wanner Journal: PLoS One Date: 2017-02-17 Impact factor: 3.240